SB 352

  • Nevada Senate Bill
  • 2023 Regular Session
  • Introduced in Senate
  • Passed Senate Apr 25, 2023
  • Assembly
  • Governor

Revises provisions relating to prescription drugs. (BDR 57-134)

Votes


Actions


May 20, 2023

Senate

(Pursuant to Joint Standing Rule No. 14.3.3, no further action allowed.)

Apr 26, 2023

Senate

From printer. To re-engrossment. Re-engrossed. Second reprint. To Assembly. In Assembly. Read first time. Referred to Committee on Commerce and Labor. To committee.

Apr 25, 2023

Senate

Taken from Secretary's desk. Placed on General File. Read third time. Amended. (Amend. Nos. 503 and 529.) Reprinting dispensed with. Read third time. Passed, as amended. Title approved. (Yeas: 21, Nays: None.) To printer.

Apr 20, 2023

Senate

From printer. To engrossment. Engrossed. First reprint. Taken from General File. Placed on Secretary's desk.

Apr 19, 2023

Senate

From committee: Amend, and do pass as amended. Placed on Second Reading File. Read second time. Amended. (Amend. No. 245.) To printer.

Mar 23, 2023

Senate

From printer. To committee.

Mar 22, 2023

Senate

Read first time. Referred to Committee on Commerce and Labor. To printer.

Bill Text

Bill Text Versions Format
As Introduced PDF
Amendment 245 PDF
Reprint 1 PDF
Amendment 503 PDF
Amendment 529 PDF
Reprint 2 PDF

Related Documents

Document Format
SB352_Conceptual Amendment_Senator Jeff Stone PDF
SB352_Work Session Document_Cesar Melgarejo_Committee Policy Analyst PDF
SB352 Proposed Amendment, submitted by R. Comis, on behalf of Nevada Association of Health Plans PDF
SB352 Letter of Support, submitted by K. Bowman, PharmD, MS, Med, President, on behalf of the Nevada Pharmacy Alliance PDF
SB352 Letter of Support, submitted by C. Mello Roberson, Southwest Regional Director for NARAL Pro-Choice America PDF
SB352 Testimony in Support, submitted by A. Magnus, Executive Director of Battle Born Progress PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Nevada Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.